Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Kadmon's peak revenue was $35.7M in 2015. The peak quarterly revenue was $14.7M in 2021(q3).
Kadmon's revenue increased from $35.7m in 2015 to $8.3M currently. That's a -76.8% change in annual revenue.
| Fiscal year / year | Kadmon revenue |
|---|---|
| 2015 | $35.7M |
| 2016 | $26.1M |
| 2017 | $12.3M |
| 2018 | $1.4M |
| 2019 | $5.1M |
| 2020 | $8.3M |
How accurately did Kadmon's revenue projections match actual performance?
Kadmon saw the greatest revenue growth in 2019, when revenue increased by 264.97%.
Kadmon had the lowest revenue growth in 2018, when revenue changed by -88.62%.
| Year | Kadmon growth |
|---|---|
| 2016 | -27%↓ |
| 2017 | -53%↓ |
| 2018 | -89%↓ |
| 2019 | 265%↑ |
| 2020 | 63%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2016 | - | $6.4M | $5.7M | $4.3M |
| 2017 | $5.6M | $3.0M | $2.3M | $1.5M |
| 2018 | $433,000 | $359,000 | $372,000 | $232,000 |
| 2019 | $241,000 | $226,000 | $226,000 | $4.4M |
| 2020 | $6.7M | $448,000 | $490,000 | $615,000 |
| 2021 | $563,000 | $197,000 | $14.7M | - |
Do you work at Kadmon?
Did Kadmon meet its revenue projections?
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 101 |
| Date Founded | 2009 |
| Headquarters | New York, New York |
| Number of Locations | 11 |
| Revenue | $8.3M |
| Net Income | -$108,913,000 |
| Gross Proft | $6.3M (2020) |
| PE Ratio | -2.48 |
| Tax Rate | 0.0% |
| Market Capitalization | $270.4M |
| Total Assets | $162,710,000 |
| Ticker | KDMN |
Kadmon received early financing of $50.0M on 2012-08-30.
| Series | Round size | Date |
|---|---|---|
| Equity | $50M | 07/2014 |
| Equity | $50M | 08/2012 |
| Investors | Security type |
|---|---|
| RA Capital Management | Post-IPO Equity - Kadmon |
| Vivo Capital | Post-IPO Equity - Kadmon |
| Acuta Capital Partners | Post-IPO Equity - Kadmon |
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Evofem Biosciences | - | $16.8M | 55 | - |
| PharmaCyte Biotech | - | $12,160 | 2 | - |
| Edgewise Therapeutics | - | $30,000 | 45 | - |
| Cerecor | - | $6.7M | 32 | - |
| Paratek Pharmaceuticals | - | $160.3M | 208 | - |
| Checkpoint Therapeutics | - | $41,000 | 7 | - |
| Aquestive Therapeutics | - | $57.6M | 100 | - |
| Allos Therapeutics | - | $76.0M | 175 | - |
| CSA Medical | - | - | 76 | - |
| Conceptus | - | $140.7M | 125 | - |
Zippia gives an in-depth look into the details of Kadmon, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Kadmon. The employee data is based on information from people who have self-reported their past or current employments at Kadmon. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Kadmon. The data presented on this page does not represent the view of Kadmon and its employees or that of Zippia.
Kadmon may also be known as or be related to KADMON HOLDINGS INC., Kadmon, Kadmon Corporation, LLC, Kadmon Holdings Inc, Kadmon Holdings, Inc. and Kadmon Holdings, LLC.